Literature DB >> 2889606

Hypothermia and poikilothermia induced by a kappa-agonist opioid and a neuroleptic.

M W Adler1, E B Geller.   

Abstract

When an opioid acting selectively at the kappa opioid receptor is administered subcutaneously to rats along with a neuroleptic at an ambient temperature of 20 degrees C a marked hypothermia ensues. The combination of U-50,488H (a kappa agonist) and chlorpromazine (a neuroleptic) caused a drop in body temperature amounting to as much as 11 degrees C, with all animals recovering after 24-48 h. Naloxone partially reversed the hypothermia. Similar, but less dramatic, decreases in body temperature occurred with other neuroleptics and weaker kappa agonists. The induction of poikilothermia was indicated when the body temperature approached the environment temperature and lethality resulted in 100% of the animals at ambient temperatures of 5 degrees C or 35 degrees C. The potential utility of this or similar combinations of drugs lies in such diverse applications as cardiac surgery, treatment of the near-drowning syndrome and space travel.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889606     DOI: 10.1016/0014-2999(87)90811-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Comparison of acid/base status in conscious and anaesthetized rats during acute hypothermia.

Authors:  V Alfaro; L Palacios
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

Review 2.  Effects of opioids, cannabinoids, and vanilloids on body temperature.

Authors:  Scott M Rawls; Khalid Benamar
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

3.  Time course of altered sensitivity to inhibitory and excitatory agonist responses in the longitudinal muscle-myenteric plexus and analgesia in the Guinea pig after chronic morphine treatment.

Authors:  Dane M Barrett; Hercules T Maguma; David A Taylor
Journal:  Front Pharmacol       Date:  2012-01-10       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.